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PREFACE
As long as I can remember, I wanted a career in the healthcare field. However, I was
unsure of my specific place in the industry. All I knew is that I wanted to make healthcare
better. I discovered quality improvement methodologies (Certified Six Sigma Black Belt) and
project management tools (Project Management Professional). Through my experience and
web-based technologies, I became proficient at implementing change across institutions in
geographically disperse locations.
I took an interest in Hospital Engagement Networks during their final year of
implementation, 2014. I was caught up in the debate on whether large-scale quality
improvement collaborations were effective at driving large-scale change. Simultaneously, I
was perplexed with the lack of technology behind the HEN program’s implementation
strategy and methodology.
It is now five years since the first HEN program’s completion, and to my knowledge,
there have been no peer-reviewed articles evaluating the effectiveness of the HEN program
compared to nonparticipants. Through my dissertation research, I hoped to understand
whether the HEN programs were successful and how such large-scale quality improvement
collaborations might improve in the future.
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In 2012, the Centers for Medicare and Medicaid Services (CMS) launched the
Hospital Engagement Network (HEN) program to decrease patient harm events in United
States’ (US) hospitals. The HEN program became the nation’s largest quality improvement
collaborative (QIC) focusing on improving patient care. Results from the program’s formal
evaluation were inconclusive on whether the HEN program was effective. There have been
no other known studies on this program’s effectiveness. Even with the evidence lacking, the
CMS continues to fund programs similar to the HEN program. This study’s research aim was
to compare patient outcomes for HEN participants to nonparticipants to evaluate the
program’s performance.
The sample contained US hospitals with at least 25 beds and reported outcome data to
Hospital Compare. A retrospective comparative analysis was performed on central lineassociated bloodstream infection (CLABSI) standardized infection ratios (SIRs) and 30-day
readmission rates for heart failure (HF), acute myocardial infarction (AMI), and pneumonia.
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In both articles, pre-post trends were analyzed using fixed effects regression models to
control for hospital characteristics and baseline performance.
For the first study, there were a total of 7,632 hospital years of data between HEN
participants (6,374) and nonparticipants (1,258). The fixed effects regression model indicated
that HEN participation did not reduce the CLABSI SIR in participating hospitals (p=.816).
When the sample was divided into three groups based on baseline performance, the HEN
participation coefficient (-.085) was moderately significant (p=.079) for the high performing
group (lowest average CLASBI SIR in 2011). For the other two groups, medium (p=.960)
and low performance (p=.848), the HEN participating coefficient was not significant.
The second study was based on a total 76,900 hospital years of data with 30-day
readmission rates for HF (28,280), AMI (20,936), pneumonia (27,684). The pre-post fixed
effect regression coefficients for HEN participation were varied for HF (.018, p=.639), AMI
(-.073, p=.032), and pneumonia (.097, p=.003). When using full panel data, the fixed effect
regression coefficients were similar to the original sample with 30-day readmission rates for
HF(-.032, p=.439), AMI (-.148, p=.001), and pneumonia (.103, p=.014). The sensitivity
analysis determined that HEN participants achieved superior AMI readmission
improvements over nonparticipants before the HEN program commenced.
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BACKGROUND
Patient Safety
Patient harm events continue to be a persistent issue in the United States (US). The
Institute of Medicine (IOM), now the Health and Medicine Division of the National
Academies of Sciences, stated in its ground-breaking report that 44,000-98,000 patients die
every year from medical harm events.1 More recent studies have shown the patient harm
events are still prevalent with little improvement.2 These patient harm incidents include
hospital-acquired conditions and associated readmissions. A hospital-acquired condition is a
condition that presents during a hospital stay that was not present on admission.3 The total
cost of patient harm events in the US ranges between $17.1 billion4 and $19 billion.5
Hospital Engagement Networks
In 2001, the IOM recommended that the US should invest in a $1 billion, three-tofive-year national patient safety initiative to catalyze a national safety movement.6 In 2010,
the Patient Protection and Affordable Care Act (ACA) commissioned the Department of
Health and Human Services (HHS) to develop a national strategy for improving patient
outcomes.7 In 2011, HHS launched the Partnership for Patients (PfP) initiative with a $1
billion budget to reduce preventable hospital-acquired conditions by 40% and readmissions
by 20%.8,9
The PfP initiative allocated $218 million to develop the Hospital Engagement
Network (HEN) program.8 The HEN program designated 26 organizations as “Hospital
Engagement Networks” to lead hospitals through quality improvement initiatives. These
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HEN organizations ranged from state hospital associations to public, for-profit companies.
They were able to recruit over 3,700 hospitals to join their programs.10
The HENs were responsible for improving eleven patient harm events: central lineassociated bloodstream infections (CLABSIs), adverse drug events, catheter-associated
urinary tract infections (CAUTIs), injuries from falls, pressure ulcers, obstetrical adverse
events, surgical site infections, venous thromboembolism, ventilator-associated pneumonia,
preventable readmissions, and early elective deliveries.8 In addition to focusing on these
patient harm areas, the HENs were tasked with decreasing 30-day all-cause readmission rates
by 20%.
While implementation models varied across the HENs, the American Hospital
Association (AHA) recommended four improvement tactics:
1. Facilitate training through a combination of face-to-face meetings and webinars (with replay
opportunities), monthly coaching calls, and hold quarterly individual calls with each participating
hospital to provide assistance gauge implementation process, identify barriers and successes and to
direct development of additional supporting resources
2. Require hospitals to report process measures to assure implementation of key process changes, and
benchmark progress
3. Provide technical assistance when triggers are hit (outliers based on data)
4. Leadership Engagement and support of unit-level activities and needs to include rounding,
understanding of data and regular reporting to Board and hospital staff. 11

Between 2010-2014, the Agency for Healthcare Research and Quality (AHRQ)
reported a 17-percent drop in hospital-acquired conditions (HACs) in the United States.12
That same report stated the United States saved approximately $19.9 billion due to the
reduction in HACs.12 AHRQ could not directly credit the HENs with the improvements.
However, the report mentioned the effects of the HEN’s catalytic effect on national patient
2

safety improvements.12 Several articles were published on the HEN programs' improvement
effects on a smaller, localized scales.13-17 The AHRQ report and additional published articles
suggested that the HEN program was having a substantial effect. However, not all patient
safety professionals were convinced about the program’s effectiveness.
Several patient safety researchers have openly criticized the HEN program with three
primary critiques.18 The first criticism is that the HENs did not standardize outcome metrics,
which would have allowed for standardized research across HENs. Second, all of the studies
conducted on the effectiveness of HENs were lacking a control group. Finally, the data,
methods, and research were not available for peer review.18 The CMS’s formal evaluation of
the HEN program addressed the latter two concerns.
In 2015, Health Services Advisory Group, Inc (HSAG) and Mathematica Policy
Research formally evaluated the HEN program’s impact on patient harm events. These two
research organizations used 2011-2014 data from Medicare claims, the Medicare Patient
Safety Monitoring System, the National Healthcare Safety Network, the National Database
of Nursing Quality Indicators, and the National Vital Statistics System.19 The researchers
utilized interrupted time series (ITS) analysis for detecting national trends in the HENs’
eleven targeted patient harm areas and difference-in-difference (DID) regression analysis to
estimate the HEN program’s effectiveness compared to nonparticipants. Of all the HENtargeted patient outcomes, the ITS analysis determined that only readmissions experienced a
positive trend change.19
The evaluators performed a DID regression analysis on six of the eleven targeted
patient outcomes. The DID analysis determined that the HEN hospitals performed better in
3

three of the six patient outcomes with moderate probability, which was defined as 60% - 80%
likelihood of cause. The three outcomes with a moderate probability of HEN’s impact were
venous thromboembolism (2-5%), pressure ulcers (25%), and central-line associated
bloodstream infections (5-10%).19 Ultimately, the formal evaluation concluded that the HEN
program’s “impact on outcomes and costs is inconclusive.”19
While it appears that the formal evaluation supports the HEN critics, the HEN
supporters countered back stating the lack of empirical evidence does not justify the HENs
ineffectiveness at driving change.20,21 These supporters argue that setting up robust process
improvement metrics, running randomized control trials, and executing intricate research
designs were not the intention of the HEN program. Indeed, the CMS intended the HEN
program to drive rapid improvements in patient outcomes not serve as an academic model for
robust research design.20 Another prominent population health researcher stated that while
quality improvement collaboration is laudable, the model needs additional peer review so
decisions moving forward can be based on data.22
Despite the lack of evidence, the CMS continues forward with quality improvement
collaborations similar to the HENs. The HEN program was followed by the Hospital
Engagement Network Round 2 program, which launched in September 2015. In Round 2,
CMS distributed $110 million for one year to 17 quality improvement organizations to
continue HENs’ original work.23 In 2016, CMS announced a further continuation of the
program with the Hospital Improvement and Innovation Networks (HIIN). CMS awarded
$347 million to 16 organizations to improve on the work started by the HEN program. This
program was funded from the end of 2016 through 2019.24 The HIIN program combined the
4

HENs with the Quality Improvement Organizations (QIOs). One complaint of the HEN
program was that its improvement effort was redundant because CMS had already
established QIOs to assist with quality improvement efforts. The HIIN program brought
together these two programs.
Literature Review
This literature review section is focused on quality improvement collaborations
(QICs), specifically the HEN program. Due to the large number of studies on QICs, there
was a strategic focus only to obtain systematic reviews. For the HEN program search, a more
granular approach was needed, and all available published articles on HENs were reviewed.
Quality Improvement Collaboration Review
The search for QIC systematic reviews was through PubMed, Ovid Medline, and
Primo. Systematic reviews are summary articles on a particular topic that use rigorous
selection criteria. There were three known systematic reviews performed on QICs in the past
decade. These reviews were published in BMJ (2008),25 Milbank Quarterly (2013),26 and
BMJ Quality & Safety (2018).27
2008 Systematic Review
Schouten et al published their 2008 QIC systematic review, Evidence for the impact
of quality improvement collaboratives: systematic review, in BMJ.25 The review started with
over 1,000 articles and concluded with nine studies that met the inclusion criteria. From those
nine studies, two showed positive QIC effects, five showed mixed effects, and two showed
no effect. The authors concluded that the impact of the QICs was positive but limited.25
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2013 Systematic Review
Nadeem et al’s systematic review, Understanding the Components of Quality
Improvement Collaboratives: A Systematic Literature Review, was published in 2013 in
Milbank Quarterly. This systematic review’s purpose was to determine what implementation
methods were consistent across QICs. Then the authors tied those components to
improvements in provider-level behavioral change and patient-level outcomes. The authors
only included articles with randomized controlled trials (RCTs) or observational studies that
were quasi-experimental (i.e., controls included).26
For provider-level outcomes, there were nine studies with positive effects, eight with
mixed effects, and two with no effect. For patient-level outcomes, there were three studies
with positive effects, six with mixed effects, and four with no effects. These authors
concluded that there was limited evidence for QICs overall effectiveness, especially for
patient outcomes.26
2018 Systematic Review
Wells et al published their 2018 QIC systematic review in BMJ Quality & Safety.27
The authors used the search methodology from Schouten et al’s 2008 systematic review. The
systematic review contained 64 studies with 39 in hospital settings. CLABSI was the
outcome variable for over 20% of the hospital-based studies.27
There was a statistically significant improvement in at least one of the targeted
outcomes in 83% of the hospital studies. The authors suggested that while the QICs appear
mostly successful in achieving their aims, there was the possibility for multiple biases in
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those studies.27 Upon reviewing all US-based studies included in this systematic review,
there were no studies that mentioned the HEN program.
Hospital Engagement Network Review
A search was performed in Ovid Medline and Google Scholar for articles with
“Hospital Engagement Network*” in the full text of articles (excluding citations).
General Descriptions of HEN Program
In the HEN program’s first couple of years, several journals published articles about
the HEN program as a potential way to improve.28-30 These articles merely described the
program and were not scientific.
Research Development
Several HEN organizations enabled research studies on qualitative research,
observational studies, dissemination efforts, and best practices. HEN programs funded
research indirectly or directly to provide HEN participants with evidence-based practices.
One such program was a 10-year follow up study to Dr. Pronovost’s foundational CLABSI
study.31 Also, HEN program staff also assisted with research studies, such as a review on
regional variation in CAUTI rates.32 One HEN reached out to its hospital members to have
them identify research priorities and developed its research agenda accordingly.33
One of the ways HENs disseminated information was through published studies.
Studies were published on patient and family engagement,34,35 lean practices,36 estimating
costs of harm events,37 ADE reductions,38,39 CAUTI improvements,40 maternal care best
practices,41 and readmission rates.42
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Defining Terms and Metrics
HENs also served the purpose of performing research to solidify definitions of terms
and validate quality improvement metrics. One HEN conducted an observational study to
ensure the correct definition for the diagnosis of CAUTIs.43 Another study validated outcome
metrics for anticoagulant-associated hemorrhages.44
Protocols
Two research protocols were developed to utilize the HEN program to deliver
interventions. However, no studies or results could be found from either protocol. One
protocol proposed to evaluate transitional care effectiveness using mixed methods.45 Another
protocol was a prospective research study with 800 hospitals targeting CAUTI reductions.46
Outcomes
Published articles and studies with patient outcomes are listed in this section. These
outcome studies were categorized into four study settings: 1) single hospital or unit 2) health
system 3) HEN 4) state or national. As expected, the smaller, more focused studies generated
more accurate data. As discussed in the background section, no studies used a control group.
Unit and Hospital
Three published studies documented HEN participating hospitals having an impact at
the unit level. Warner et al documented the decrease of pressure ulcers in a hospital’s burn
unit.17 Rhone et al recorded improvements in catheter insertion techniques in a 1,000+ bed
hospital’s emergency department.47 Rosenberg et al reported CLABSI reductions in an
academic medical center’s large pediatric unit.48
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Six published research articles on HEN improvement efforts came from individual
hospital settings. Tuttle reported a CAUTI reduction in a 600-bed hospital’s critical care
units.49 Story documented a 500-bed hospital decreasing overall CLABSIs.50 Francis
recorded a 230-bed hospital’s reduction in Clostridium difficile infections.51 Philips et al
reported a 145-bed pediatric hospital’s decline in the number of hospital-acquired conditions
through the HEN program.52 Adams et al documented a rural hospital’s reduced readmission
rates.14 Kles et al recorded a 350-bed hospital’s decreased surgical site infections.53
System
There were four studies at the system level, and these studies did not have the
methodological rigor as the hospital and unit studies. Fakih et al documented catheter
placement improvement in 18 emergency departments.54 Frush et al recorded two health
systems that showed overall safety culture improvements attributed to HEN participation.55
Eugene A. Woods, president of then Carolinas HealthCare System, stated that HEN
participation helped them to prevent over 13,000 patient harm events resulting in $80 million
in cost savings.56 Hendrich and Haydar reported how one health system used the HEN
program as a step on its official high-reliability journey.57
Hospital Engagement Network
At the HEN level, twelve studies, including a mix of qualitative and quantitative
methods, were published on HEN participation and outcomes achieved. One HEN decreased
falls by almost 40% across 23 hospitals.58 Two reports stated that rural hospitals, in
particular, achieved broad performance improvement gains through the HENs.59,60 Other
studies at the HEN level included opioid awareness interventions,61 decreasing patient falls,62
9

and reducing early elective deliveries.63 Two studies evaluated the effect of hospital
leadership engagement within the HEN program.64,65
The Children’s Hospitals’ Solutions for Patient Safety (SPS) HEN had the most
publications of all the HENs. The SPS HEN started with 33 hospitals and has since
expanded. This HEN published improvement studies on surgical site infection reductions,66
pressure injury declines,67 and overall improvement gains.68,69
State/Nation
Only one study was published evaluating the HEN’s impact on patient outcomes at
the state level. California developed and sustained better maternal outcomes as a state
compared to other states. The researchers cited the HEN program as one of the many
programs that contributed to better outcomes.70 One possible reason for the lack of HEN
research at the state level is because HENs did not always operate within state boundaries.
An Iowa-based qualitative study researched how the state attempted to increase cohesiveness
between all the state-level quality improvement programs.71
On the national level, over a dozen publsiehd articles declared the HEN program’s
impact on improving patient outcomes. A report in the American Journal of Health-System
Pharmacy stated that HENs had decreased adverse drug events by more than 40% across the
nation.13 In a 2018 Health Affairs article, Donald Berwick, former CMS administrator, cited
the HENs as a success and an improvement model to be emulated.21 Eleven articles
mentioned that the HEN program played a role in improving patient care, but these articles
did not provide any evidence of the program’s effectiveness.72-82
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Criticisms
Pronovost and Jha expressed three criticisms with the HEN program. The first
criticism is that the HENs did not standardize outcome metrics, which would have allowed
for standardized research across HENs. Second, all of the studies conducted on the
effectiveness of HENs were lacking a control group. Finally, the data, methods, and research
were not available for peer review.18 Mendel et al published an article emphasizing the risk
change fatigue brought about by a large number of national and regional quality
improvement initiatives.83
Confounding Other Research
Ryan et al’s article on readmissions and federal government interventions described
how participating in value-based payment programs decreased readmissions. Their study’s
first limitation was that they could not control for all improvement activities underway at that
time and explicitly cited the HEN program.84
Public Health Significance
The $212 million HEN program has yet to be proven effective at implementing largescale change. The CMS’s $9 million formal evaluation stated that the HEN program’s
“impact on outcomes and costs is inconclusive.”19 No known published studies have
compared HEN participation to nonparticipation. The federal government continues to spend
millions of dollars on QICs (e.g., HEN program), yet, there is no empirical evidence that
hospitals participating in these programs achieve better outcomes than nonparticipants. This
research study was the first known study to have evaluated patient care outcomes between
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HEN participants and nonparticipants. The results from this study add to the discussion on
whether national QIC programs should continue.
Conceptual Framework
Based on Donabedian’s model, researchers at the University of Wisconsin-Madison
developed an improvement model titled the Systems Engineering Initiative for Patient Safety
(SEIPS).85,86 The SEIPS model separated Donabedian’s structural component into five areas
within the work system: 1) the person 2) physical environment 3) organization 4) technology
and tools 5) tasks.86 At the center of the work system was the person who influences,
changes, and improves the other structural components. These structural modifications
influenced the care provided and ultimately, patient outcomes.
Figure 1 displays this study’s conceptual framework which is built on Donabedian’s
model and the SEIPS model. When hospitals chose to participate in the HEN program, access
to coaching, best practices, webinars, and other resources became available. A person at the
hospital consumed this content improved work systems. As previously noted, changes to
these work systems eventually improved patient outcomes. However, there were additional
hospital characteristics which are also structural components, but these characteristics were
not easily changed (bed size, disproportionate share (DSH), and case mix index (CMI). These
structural attributes also influence care processes which affect patient outcomes (CLABSIs
and readmissions for this study).
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Figure 1: Conceptual Framework

Figure 2 displays the HEN program’s implementation overview from policy
development through improved patient care outcomes. The ACA provisioned funding for
Patient-Centered Outcomes Research Trust Fund (PCORTF) and Centers for Medicare and
Medicaid Innovation (CMMI). The PCORTF endowed PCORI and AHRQ to fund research
organizations to develop evidence-based practices (EBPs). The HENs disseminated EBPs
through hospital quality improvement (QI) leads. The QI leads subsequently worked with
multidisciplinary teams to change the hospitals’ work system elements, as discussed
previously in the conceptual framework. Again, using Donabedian’s approach, the improved
structural components facilitated better processes and ultimately improved outcomes.
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Figure 2: Implementation Overview

Table 1: Conceptual Framework Abbreviations
Conceptual Framework Abbreviations
Abbreviation
AHRQ
CLABSI
CMMI
CMI
CMS
DSH

Term

Abbreviation

Agency for Healthcare Research
and Quality
Central Line-associated
Bloodstream Infection
Center for Medicare and Medicaid
Innovation

HEN
HHS
PCORI

Case Mix Index

PCORTF

Centers for Medicare & Medicaid
Services
Disproportionate Share

14

Term
Hospital Engagement Network
Department of Health and Human
Services
Patient-Centered Outcome Research
Institute
Patient-Centered Outcomes Research
Trust Fund

PfP

Partnership for Patients

QI

Quality Improvement

Aim and Research Questions
This study aimed to evaluate whether hospitals participating in a HEN obtained
superior patient outcomes compared to hospitals that did not participate. This aim was
achieved by answering two research questions: 1) Did HEN participation lead to decreased
central line-associated bloodstream infections (CLABSIs)? 2) Did HEN participation lead to
reductions in 30-day readmission rates for heart failure (HF), acute myocardial infarction
(AMI), and pneumonia?
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METHODS
Study Design
A retrospective comparative analysis was completed between HEN participants and
nonparticipants with CLABSI SIRs and 30-day readmission rates (HF, AMI, pneumonia) as
outcome variables. In the first article, CLABSI SIRs were compared between HEN
participants and nonparticipants using a fixed effects regression model with annual data from
2011 through 2014. Similarly, in the second article, 30-day readmission rates were compared
using a fixed effects regression model with 36-month rolling average data from 2008 through
2017. In both articles, pre-post trends were analyzed while controlling for hospital
characteristics.
Data Collection
The research database consisted of data from several different public-use data files
that linked individual hospitals using the Medicare Provider Identification Number. The
outcomes (for CLABSIs and 30-day readmissions) were collected from the CMS’s Hospital
Compare archived data repository for a national sample of hospitals identified as general
acute care with at least 25 inpatient beds.87 Veterans Affairs (VA) hospitals, rehabilitation
hospitals, dedicated cancer centers, children’s hospitals, mental health facilities, psychiatric
hospitals, and long-term care facilities were excluded. HEN participation was determined for
the hospital sample from the “HEN Round 1 hospitals 2015” spreadsheet on the CMS
Achieved Materials for the Partnership for Patients website.88
CMS annual impact files were used to determine core-based statistical areas (CBSA),
US regional location, teaching hospital status, and disproportionate share (DSH) ratio. When
16

available, the correction notice data was used instead of the final rule data. Ownership and
state variables were obtained from the Hospital Compare’s archived flat file “Hospital
General Information.” Hospital Compare’s FY12 and FY18 files were used for the first and
second article, respectively.
Data Variables
For article 1, the outcome variable, CLABSI SIR, was a ratio between observed and
expected CLABSIs. Observed CLABSIs was the numerator, and the denominator was
expected CLABSIs. Expected CLABSIs are adjusted based on the type of patients that the
facility treats (e.g., patient care location, bed size of patient care location, and association
with a medical school).89 The SIR is interpreted similarly to an odds ratio (i.e., a SIR of
below one represents the hospital had a fewer CLABSIs than expected).
For article 2, each hospital’s HF, AMI, and pneumonia 30-day readmission rates were
obtained for each year. The rates represent the moving average of 36-months of data. For
instance, the fiscal year (FY) 2013 file contained data from July 2009 to June 2012. For the
final year of the regression analysis, 2012, the readmission data from the FY13 file were
used. The final year of the three-year moving average period was used for each study year.
For example, 2010 through 2013 data were used for 2013. This method is commonly used
when the three-year readmission rate is substituted for annual data.84
Time-invariant variables (US region, state, CBSAs, teaching designation, and
ownership) were used as controls in the descriptive analyses and the ordinary least squares
(OLS) regression models. The CMS impact file used the US Census Bureau’s classification
for regions: New England, Mid Atlantic, South Atlantic, East North Central, East South
17

Central, West North Central, West South Central, Mountain, and Pacific. The CBSA variable
was categorized as large urban, other urban, or rural. The ownership variable was categorized
into government-owned, private nonprofit, and for profit. To address skewness, the
disproportion share ratio and the number of staffed beds variables were log-transformed.
Statistical Analysis
For both articles, the variables were categorized into time-invariant and time-varying
for the descriptive analysis. The Hausman test was used to determine if a fixed effects or
random effects regression model was best for the data. Hospital-level data were analyzed
using several different multivariate fixed effects regression models with CLABSI SIR and
30-day readmissions as the dependent variables. The fixed effects regression model uses
panel data to measure variation within a single hospital over time. In other words, this model
uses each hospital as its own control.90 The fixed effects model includes time-varying,
independent variables for the number of staffed beds and the disproportionate share ratio.
Case mix index (CMI) was included in the first article.
Article 1
For 2011 data, all hospitals were assigned to the control group since the HEN
program did not commence until 2012. Then for 2012 through 2014 data, the HEN
participants were assigned to the intervention group while keeping nonparticipants in the
control group. This binary change from 0 to 1 for HEN participation enabled the capturing of
a HEN participation coefficient.
The data were further analyzed to determine if the starting performance affected the
HENs’ impact on CLABSIs. The sample was divided into thirds based on 2011 CLABSI
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SIRs, and a fixed effects regression model was conducted. Since there was only one period of
pre-intervention data (2011), separating the sample this way controlled for possible bias.
Hospitals were categorized as high performing (SIR <.25), average (SIR between .25-.69), or
low performing (SIR >.7) with a third of the sample in each category.
Finally, the CLABSI SIR variable was zero in 16% of the observations. The CLABSI
SIR was converted into a binary variable by coding hospitals that experienced a CLABSI as
one and non-CLABSI hospitals as zero. The binary CLABSI SIR was regressed on timevarying, independent variables previously listed by using a logit fixed effects model.
The statistical analyses were completed using Stata v14.2, College Station, Texas. 91
Article 2
30-day readmission rates were graphed for ten periods and categorized by HEN
participation and nonparticipation. An ordinary least squares (OLS) regression model of
readmissions was estimated for 2008 through 2011 using a binary variable for HEN
participation as a way to compare HEN participant to nonparticipant performance before the
program started.
For the fixed effects model, a binary variable for HEN participation was zero for all
hospitals through five periods (2008 through 2012). Starting in the sixth period (ending in
June 2013), HEN participation was labeled as one and nonparticipation as zero. This variable
allowed for testing the effect of HEN participation on the readmission rate while controlling
for other time-invariant and time-varying variables. Hospitals with missing outcome data
were removed, and the fixed effects regression model was executed again to determine if
strongly balanced panels achieved the same results.
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To check the validity of the model, two sensitivity analyses were performed. The first
analysis determined the effect of changing the intervention period in the fixed effects model.
In the original fixed effects regression, the HEN coefficient was assigned to the start of
period six (July 2010 through June 2013). The HEN coefficient variable was then assigned to
the start of periods four, five, and seven. The second analysis was to determine the HEN
program’s effect during and after the intervention. Periods nine (July 2013 through June
2016) and ten (July 2014 through June 2017) were omitted, and the fixed effects regression
model was executed again.
Human Subjects, Animal Subjects, or Safety Considerations
The University of Texas School of Public Health’s Institutional Review Board
determined this study was exempt from human subjects’ protection (HSC-SPH-18-0470,
HSC-SPH-0376).
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JOURNAL ARTICLE #1
Hospital Engagement Network Participation and Central Line-associated Bloodstream
Infections
Journal of Patient Safety
Abstract
Objective
In 2012, the Partnership for Patients program launched the Hospital Engagement
Network (HEN) program to reduce eleven types of patient harm events in United States
hospitals. Evaluation research on the HEN program and other national quality improvement
collaborations has yet to show definitive results. A formal evaluation of the HEN program
determined that HEN participations probably outperformed nonparticipating in reducing
three types of patient harm events, one of which was central-line associated bloodstream
infections (CLABSIs). The effectiveness analysis was ultimately inconclusive.
Despite the lack of empirical evidence, the collaboration improvement model
continued. There was a divide between individuals who believe the model should be
continued and others who want the model to be further validated as effective. The purpose of
this study was to provide further evidence of the impact of the HEN program by replicating
the findings of the formal evaluation regarding HEN-attributable CLABSI improvement in
participating hospitals using a national dataset and multiple regression analyses.
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Methods
We completed a comparative retrospective analysis of the CLABSI standardized
infection ratio (SIR) from 2011 through 2014 in 1,650 HEN hospitals and 329 control
hospitals. The CLABSI SIR was regressed on time-varying, independent variables using a
fixed effects model. The regression model was reestimated separately for hospitals
categorized as high, medium, and low performers based on 2011 CLASBI SIR data. In
addition, a logit fixed effects regression model was used to test the relationship by converting
the CLABSI SIR into a binary dependent variable for CLABSI occurrence.
Results
The fixed effects regression model indicated that HEN participation did not reduce
the CLABSI SIR in participating hospitals (p=.816). When the sample was divided into three
groups based on baseline performance, the HEN participation coefficient (-.085) was
significant at the 10% confidence level only for the high performing group (lowest average
CLASBI SIR in 2011, p=.079). For the other two groups, medium SIR (p=.960) and low SIR
(p=.848), the HEN participating coefficient was not significantly better than controls. The
logit model also produced a nonsignificant HEN coefficient (p=.786).
Conclusions
This study was unable to show that HEN participation generated CLABSI
improvement over the study period using a national hospital database and different regression
models. However, there was a slight improvement in high performing hospitals. Additional
research is needed to determine if the program may have improved other patient harm events
targeted by the HEN program.
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Introduction
In 2001, the Institute of Medicine (IOM) recommended that the United States (US)
invest in a $1 billion, three- to five-year national patient safety initiative to catalyze a
national safety movement.1 Nearly a decade later, the Patient Protection and Affordable Care
Act (ACA) commissioned the Department of Health and Human Services (HHS) to develop
a national strategy for improving patient outcomes.2 In 2011, HHS launched the Partnership
for Patients (PfP) initiative with a $1 billion budget to reduce preventable hospital-acquired
conditions by 40% and readmissions by 20%.3,4
The PfP initiative allocated $218 million to develop the Hospital Engagement
Network (HEN) program.3 The HEN program designated 26 organizations as “Hospital
Engagement Networks” to lead hospitals through quality improvement initiatives. These
HEN organizations ranged from state hospital associations to for-profit companies. The
HENs were able to recruit over 3,700 hospitals to join their programs (roughly 72% of all US
hospitals).5
The HENs were responsible for improving eleven patient harm events: central lineassociated bloodstream infections (CLABSIs), adverse drug events, catheter-associated
urinary tract infections, injuries from falls, pressure ulcers, obstetrical adverse events,
surgical site infections, venous thromboembolism, ventilator-associated pneumonia,
preventable readmissions, and early elective deliveries.3
Implementation models varied across the HENs, but all followed the four American
Hospital Association (AHA) recommended improvement tactics:
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“1. Facilitate training through a combination of face-to-face meetings and webinars (with replay
opportunities), monthly coaching calls, and hold quarterly individual calls with each participating
hospital to provide assistance gauge implementation process, identify barriers and successes and to
direct development of additional supporting resources
2. Require hospitals to report process measures to assure implementation of key process changes, and
benchmark progress
3. Provide technical assistance when triggers are hit (outliers based on data)
4. Leadership Engagement and support of unit-level activities and needs to include rounding,
understanding of data and regular reporting to Board and hospital staff.” 6

Initial reports appeared that the HENs achieved significant patient harm
improvements. Between 2010 through 2014, AHRQ reported a 17 percent drop in hospitalacquired conditions (HACs) in the US.7 That same report stated the US saved approximately
$19.9 billion due to the reduction in HACs.7 AHRQ could not directly credit the HENs with
the improvements. However, the report mentioned the HENs catalytic efforts on reducing
patient harm.7 Numerous studies were published suggesting HEN participants had decreased
patient harm events, but none of these studies used control groups.8-12 While the HEN
outcomes appeared promising, not all patient safety professionals were convinced.
Several patient safety researchers have openly criticized the HEN program with three
primary critiques.13 The first is that the HENs did not standardize outcomes metrics which
would have allowed for standardized research across HENs. Second, all research studies
conducted on the effectiveness of HENs before 2014 were lacking a control group. Finally,
the data, methods, and research were not available for peer review.13 CMS commissioned a
formal evaluation of the HEN program to address the latter two concerns.
In 2015, Health Services Advisory Group, Inc (HSAG) and Mathematica Policy
Research formally evaluated the HEN program’s impact on patient harm events. These two
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research organizations used 2011 through 2014 data from Medicare claims, the Medicare
Patient Safety Monitoring System, the National Healthcare Safety Network, the National
Database of Nursing Quality Indicators, and the National Vital Statistics System.14 The
researchers utilized interrupted time series (ITS) analysis for detecting national trends in the
HENs’ eleven targeted patient harm areas difference-in-difference (DID) regression analysis
to estimate the HEN program’s effectiveness compared to nonparticipants. The ITS analysis
determined that none of the patient harm areas experienced a national positive trend
change.14 The DID analysis determined that the HEN hospitals performed better in three of
the six patient outcomes with moderate probability, defined as 60% to 80% likelihood of
causality. The three outcomes with a moderate probability of the HEN’s impact were venous
thromboembolism (2-5%), pressure ulcers (25%), and CLABSIs (5-10%).14
Ultimately, the formal evaluation concluded that the HEN program’s “impact on
outcomes and costs is inconclusive.”14 While it appeared that the formal evaluation did not
validate the HEN program’s effectiveness, HEN supporters countered by stating the lack of
empirical evidence did not justify concluding that the HEN program was ineffective in
driving change.15,16
One leader in population health stated that while quality improvement collaboration is
laudable from a theoretical perspective, the industry needs empirical evidence for decisions.17
Despite the lack of evidence, CMS continued with quality improvement collaborations
similar to the HENs.
The purpose of this study was to contribute to the HEN discussion by evaluating the
effectiveness of the HENs in decreasing CLABSIs compared to nonparticipants. It is the first
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known study to examine the HEN program’s outcomes with a nonparticipating control group.
The outcome variable was the CLABSI standardized infection ratio (SIR) as documented in
Hospital Compare. The focus on CLABSIs was because the formal evaluation found a
moderate probability of likelihood of HEN hospitals outperforming nonparticipants on this
particular measure, and CLABSI data were publicly available.
Methods
Study Design
We compared CLABSI SIRs between HEN participants and nonparticipants using a
fixed effects regression model with annual data for 2011 through 2014. Pre-post trends were
analyzed while controlling for hospital characteristics. The University of Texas School of
Public Health’s Institutional Review Board determined this study was exempt from human
subjects’ protection.
Data Collection
The research database consisted of data from several different public-use data files
that linked individual hospitals using the Medicare Provider Identification Number. We
collected CLABSI outcome from the CMS’s Hospital Compare archived data repository for a
national sample of hospitals identified as general acute care with at least 25 inpatient beds.18
Veterans Affairs (VA) hospitals, rehabilitation hospitals, dedicated cancer centers, children’s
hospitals, mental health facilities, psychiatric hospitals, and long-term care facilities were
excluded. HEN participation was determined for the hospital sample from the “HEN Round
1 hospitals 2015” spreadsheet on the CMS Achieved Materials for the PfP website.19 CMS
annual impact files for fiscal years (FY) 2012 through 2015 were used to determine core26

based statistical areas (CBSA), US regional location, teaching hospital status, and
disproportionate share (DSH) ratio. When available, the correction notice data was used
instead of the final rule data. Ownership and state variables were obtained from the Hospital
Compare’s FY12 archived flat file “Hospital General Information.”
Data Variables
The outcome variable, CLABSI SIR, is a ratio between observed and expected
CLABSIs. The numerator was observed CLABSIs with the denominator as expected
CLABSIs. Expected CLABSIs are adjusted based on the type of patients that the facility
treats (e.g., patient care location, bed size of patient care location, and association with a
medical school).20 The SIR is interpreted similarly to an odds ratio (i.e., a SIR of below one
represented the hospital had a fewer CLABSIs than expected).
Time-invariant variables (US region, state, CBSAs, teaching designation, and
ownership) were used as controls in the descriptive analyses and the ordinary least squares
(OLS) regression models. The CMS impact file used the US Census’s classification for
regions: New England, Mid Atlantic, South Atlantic, East North Central, East South Central,
West North Central, West South Central, Mountain, and Pacific. The CBSA variable was
categorized as large urban, other urban, or rural. We categorized the ownership variable into
government-owned, private nonprofit, and for profit. We log-transformed the disproportion
share ratio and the number of staffed beds variables to address skewness.
Statistical Analysis
The variables were categorized into time-invariant and time-varying for the
descriptive analysis. The Hausman test was used to determine if a fixed effects or random
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effects regression model was best for the data. We analyzed hospital-level data using several
different multivariate fixed effects regression models with CLABSI SIR as the dependent
variable. The fixed effects regression model uses panel data to measure variation within a
single hospital over time. In other words, this model uses each hospital as its own control.21
The fixed effects model includes time-varying, independent variables for the number of
staffed beds, DSH ratio, and case mix index (CMI).
To capture HEN participation, we assigned the binary variable of 0 for
nonparticipation and 1 for participation. This change from 0 to 1 in HEN participation
enabled us to capture a coefficient for HEN participation. For 2011 data, we assigned all
hospitals with a variable of 0 since the HEN program did not commence until 2012. Then for
2012 through 2014 data, we assigned HEN participants with a 1 for the HEN participation
variable.
We further analyzed the data to determine if the starting performance affected the
HENs’ impact on CLABSIs. We divided the sample into thirds based on 2011 CLABSI SIRs
and conducted a fixed effects regression model. Since there was only one period of preintervention data (2011), separating the sample this way controlled for possible bias. We
categorized hospitals as high performing (SIR <.25), average (SIR between .25-.69), or low
performing (SIR >.7) with a third of the sample in each category.
Finally, the CLABSI SIR variable was zero in 16% of our observations. We
converted the CLABSI SIR into a binary variable by coding hospitals that experienced a
CLABSI as one and non-CLABSI hospitals as zero. We then regressed the binary CLABSI
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SIR on time-varying, independent variables previously listed by using a logit fixed effects
model. The statistical analyses were completed using Stata v14.2, College Station, TX. 22
Results
Descriptive Statistics
Our sample contained 1650 HEN participating hospitals from each of the 26 HENs
and 329 nonparticipating hospitals. Our sample’s HEN participation rate of 83% was well
above the national average of 72%. We addressed this disparity as a limitation in the
discussion section.
Table 1 displays the time-invariant characteristics of the hospitals. HEN participation
was disproportionately smaller in the West South Central Region (Oklahoma, Arkansas,
Texas, Louisiana) and South Atlantic Region (Maryland, Delaware, West Virginia, Virginia,
North Carolina, South Carolina, Georgia, Florida, District of Columbia). Another difference
between the two groups was the high proportion of for-profit hospitals in the nonparticipation
group. Finally, while the majority of HEN participants were teaching hospitals, this was only
true for a third of the nonparticipants.
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Table 1: Descriptive Statistics for Time-invariant Variables
Descriptive Statistics for Time-invariant Variables
Variables
Region
New England
Mid Atlantic
South Atlantic
East North Central
East South Central
West North Central
West South Central
Mountain
Pacific
Geography
Rural
Small Urban
Large Urban
Teaching
Yes
No
Ownership
Government
Private Nonprofit
For Profit

HEN Participants
n (% of sample)

Nonparticipants
n (% of sample)

66 (4.04%)
251 (15.35%)
285 (17.43%)
263 (16.09%)
110 (6.73%)
111 (6.79%)
167 (10.21%)
115 (7.03%)
267 (16.33%)

25 (7.67%)
7 (2.15%)
97 (29.75)
48 (14.72%)
19 (5.83%)
8 (2.45%)
65 (19.94%)
18 (5.52%)
39 (11.96%)

139 (8.5%)
627 (38.35%)
869 (53.15%)

14 (4.29%)
133 (40.8%)
179 (54.91%)

832 (50.89%)
803 (49.11%)

121 (37.12%)
205 (62.88%)

222 (13.72%)
1,170 (72.31%)
226 (19.32%)

22 (6.92%)
148 (46.54%)
148 (46.54%)

Table 2 displays the time-varying hospital characteristics from the 2011 data that
were used in the fixed effects regression model and the CLABSI SIR by year. On average,
nonparticipants had a lower case mix index, fewer beds, and higher disproportionate share
ratio than the HEN participants. The CLABSI SIR was lower for HEN participants than
nonparticipants in each of the four years. Moreover, the average CLABSI SIRs decreased
every year for both HEN participants and nonparticipants.
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Table 2: Descriptive Statistics for Time-varying Variables in 2011
Time-varying Hospital Characteristics in 2011
Variables
Fixed Effect Variables
Case Mix Index (2011)
Beds (2011)
DSH Ratio (2011)
CLABSI SIRs by Year
2011
2012
2013
2014

HEN Participants
Mean (sd)

Nonparticipants
Mean (sd)

P-value (t-test)

1.59 (.226)
284.7 (191.4)
.285 (.17)

1.54 (.253)
242.0 (179.8)
.312 (.20)

<.001
<.001
<.02

.549 (.604)
.559 (.526)
.512 (.479)
.454 (.442)

.661 (.689)
.648 (.640)
.583 (.591)
.569 (.697)

<.001
<.001
<.03
<.001

Fixed-effects Results
The Hausman test (p<.01) confirmed that only the fixed effects regression model
should be estimated for both the fixed effects regression and logit regression with fixed
effects.
Table 3 displays the results of our first fixed effects regression model. The HEN
participation coefficient was .007 (p=.816). The only independent variable with a statistically
coefficient was 2014. On average, all hospitals had lower CLABSI SIRs in 2014 compared to
2011, with a statistically significant coefficient of -.089 (p=.005).
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Table 3: CLABSI SIR Fixed-effects Regression
CLABSI SIR Fixed-effects Regression
Variables
Coefficient
In Hen
No (reference)
Yes
.007
-.076
Beds (log)
-.003
DSH (log)
-.010
CMI
Year
2011 (reference)
2012
.003
2013
-.046
2014*
-.089
* Statistically significant at p < .05

P-value

95% C.I.

.816
.379
.940
.374

-.056
-.247
-.093
-.319

.071
.094
.086
.120

.918
.138
.005

-.058 .064
-.108 .015
-.152 -.027

Table 4 summarizes the results of the fixed effect regression model when the sample
was divided into thirds based on 2011 CLABSI SIRs. Based on the baseline year of 2011,
hospitals were categorized as high performing (SIR score <.25), average (.25-.69), or low
performing (>.7). The only group with a significant HEN participation coefficient was the
high performing group (-.085, p=.079). Both high performing and low performing groups
experienced a regression to the mean by having three statistically significant years (2012,
2013, 2014) compared to their 2011 baselines (p<.001).
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Table 4: Fixed Effects Regression with SIR Score Grouped by 2011 Baseline
Fixed Effects Regression with SIR Score Grouped by 2011 Baseline
High Performing
Variables
Coefficient
P-value
In Hen
No (reference)
Yes
-.085
.079
-.021
.863
Beds (log)
-.033
.651
DSH(log)
.195
.257
CMI
Year
2011(reference)
2012
.417*
.001
2013
.434*
.001
2014
.382*
.001
* Statistically significant at p < .05

Average
Coefficient
P-value

Low Performing
Coefficient
P-value

.002
-.123
-.131
-.108

.960
.302
.085
.478

-.011
-.049
-.002
-.185

.848
.779
.976
.360

.095*
.057
.035

.028
.192
.425

-.404*
-.533*
-.591*

.001
.001
.001

Finally, we converted the CLABSI SIR into a binary variable by coding hospitals that
experienced one or more CLABSI cases during the year as one and hospitals with no
CLABSI cases as zero. We then regressed the binary CLABSI SIR on time-varying,
independent variables by using a logit fixed effects regression model. The results of this
regression are summarized in Table 5. As indicated in the table, there was no significant
relationship between HEN participation and CLABSI events (p=.786).
Table 5: Logit Fixed Effects Regression
CLABSI SIR Logit Fixed Effects Regression
Variables
Coefficient
In Hen
No (reference)
Yes
-.051
-.360
Beds (log)
.063
DSH (log)
.404
CMI
Year
2011 (reference)
2012
.142
2013
.176
2014*
.125
* Statistically significant at p < .05
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P-value

95% C.I.

.786
.484
.833
.555

-.418 .316
-1.369 .648
-.524 .650
-.940 1.749

.423
.324
.488

-.058 .064
-.108 .015
-.152 -.027

Conclusions
Our study added further empirical evidence to the ongoing debate on whether largescale quality improvement collaborations, such as the HEN program, have been effective.
We were unable to corroborate the formal HEN evaluation that HEN hospitals decreased
CLABSI rates with HEN participation. The one exception is that high performing hospitals
experienced a moderate improvement from HEN participation (-.085, p=.079). Both HEN
hospitals and nonparticipants decreased their CLABSI SIR over four years, 17% and 14%
respectively.
It is unknown what precisely was driving the CLABSI improvements at this time.
Additionally, it is unknown how nonparticipants were able to achieve similar improvement
results to the HEN participants.
One possibility is that the nonparticipating hospitals gained quality improvement
knowledge through “spillover.”14 For instance, the nonparticipating hospitals may have
experienced some benefits (e.g., receiving toolkits, attending conferences, viewing webinars)
without participating in time-intensive tasks such as regular reporting of process measures
and attending mandatory meetings.
Increasing healthcare market pressures such as value-based purchasing, increased
consumer demands, mandated reporting requirements, and reimbursement withheld for poor
quality may have contributed to CLABSI declines.
The final interpretation of the insufficient findings was that the HENs were not
effective in delivering quality improvement interventions. This study is consistent with the
existing QIC studies that suggested these types of collaborations have generated minimal
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sustained improvements. Additionally, the HENs, as QICs, might have experienced
diminishing returns on their efforts. On the national level, new quality improvement models
may be needed to scale future interventions.
Limitations
This study has several limitations for consideration. The first limitation is that critical
access hospitals (CAHs) were omitted because CMS did not report CAH CLABSI data in
2011. Omitting these hospitals likely created sampling bias. For instance, in our study, we
had a HEN participation rate of 83%. However, the national average HEN participation rate
was approximately 72%. Due to the CAH omissions, our study was missing the proportionate
amount of controls.
The inability to quantify motivation is a common limitation of quality improvement
observational studies. As such, this study does not have a variable to capture a hospital’s
willingness to improve. Hospitals with a high motivation to improve might have been more
likely to join a HEN. Therefore, it was the desire to improve that led to better outcomes, not
necessarily HEN program participation. 23
The CLABSI SIR data were only available from 2011 through 2014, which resulted
in a short time-series panel. CLABSI SIR data before 2011 was not available in the Hospital
Compare data archive. In 2015, the National Healthcare Safety Network (NHSN) updated
how the CLABSI SIR was calculated.24 Therefore, we were unable to directly compare 2015
CLABSI SIR data with the other years in our panel.
Omitted variable bias was a concern with this study. Several quality improvement
efforts were ongoing at this time, such as Meaningful Use, accountable care organizations,
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and bundled payments.25 Our research did not control for other improvement efforts in which
hospitals could have participated.
Additional Research
Our study reviewed one of the 11 patient harm outcomes targeted by the HEN
program. Further research is needed on other outcomes to determine if the results are similar.
Additional research is needed to understand why there was such a reduction in CLABSIs
between 2011 and 2014. Several policy changes, improvement efforts, and technology
enhancements were underway during this time. Therefore, it will be challenging to find the
primary source of improvement. Recent research states it was most likely a combination of
events working in tandem.25
In the future, quality improvement research should also consider conducting
prospective cost-effectiveness analyses of QICs interventions. The cost-effectiveness
perspective is essential if QICs were effective but started to experience diminishing returns.
Understanding the actual cost of these national QIC interventions is necessary to determine
the cost per outcome gained is justified.
Finally, the HEN program’s new iterations should be researched and evaluated.
Launched in 2015, HEN 2.0 followed in the footsteps of the original HEN program. In
version 2.0, CMS distributed $110 million for one year to 17 quality improvement
organizations to continue the HENs’ original work.26 In 2016, CMS announced a further
continuation of the program with the Hospital Improvement and Innovation Networks
(HIIN). CMS awarded $347 million through 2019 to 16 organizations to improve on the
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work started by the HEN program. 27 However, there have been no studies reviewing the
effectiveness of these programs, and we are unaware of any future evaluations.
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Abstract
Objective
This study evaluated the impact of Hospital Engagement Network (HEN)
participation on 30-day readmission rates for heart failure (HF), acute myocardial infarction
(AMI), and pneumonia.
Method
We completed a comparative retrospective analysis of HEN hospitals and control
hospitals utilizing Hospital Compare’s 30-day readmission data from 2005-2017. We
regressed changes in 30-day readmission rates for HF, AMI, and pneumonia on time-varying,
independent variables using a fixed effects regression model and conducted multiple
sensitivity analyses.
Results
There were a total of 76,900 hospital years of data with 30-day readmission rates for
HF (28,280), AMI (20,936), pneumonia (27,684). The pre-post fixed effect regression
coefficients for HEN participation were varied for HF (.018, p=.639), AMI (-.073, p=.032),
and pneumonia (.097, p=.003). When using full panel data, the fixed effect regression
coefficients were similar to the original sample with 30-day readmission rates for HF(-.032,
p=.439), AMI (-.148, p=.001), and pneumonia (.103, p=.014). The sensitivity analysis
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determined that HEN participants achieved superior AMI readmission improvements over
nonparticipants before the HEN program commenced.
Conclusions
In this study, we determined that there is little evidence that HEN participation in
reducing 30-day readmissions. Policymakers should consider the lack of improvement
evidence in contemplating the future of the national quality improvement collaborations.
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Introduction
In 2001, the Institute of Medicine (IOM) recommended that the United States should
invest in a $1 billion, three-to-five-year national patient safety initiative to catalyze a national
safety movement.1 In 2010, the Patient Protection and Affordable Care Act (ACA)
commissioned the Department of Health and Human Services (HHS) to develop a national
strategy for improving patient outcomes.2 In 2011, HHS launched the Partnership for Patients
(PfP) initiative with a $1 billion budget to reduce preventable hospital-acquired conditions by
40% and readmissions by 20%.3,4 A 20% reduction in readmissions would have resulted in a
decline of 1.6 million readmissions.3
The PfP initiative allocated $218 million to develop the Hospital Engagement
Network (HEN) program.3 The HEN program designated 26 organizations as “Hospital
Engagement Networks” to lead hospitals through quality improvement initiatives. These
HEN organizations ranged from state hospital associations to for-profit companies. The
HENs were able to recruit over 3,700 hospitals to join their programs.5
The HEN program was a result of the federal government’s increasing reliance on
Quality Improvement Collaborations (QICs) to implement large-scale change. QICs were
defined as multiorganizational systems striving together to improve patient outcomes.6 The
Institute for Healthcare Improvement’s (IHI) Breakthrough Series formalized and codified
the modern QIC structure.7 Effectiveness studies on QICs have been mixed.6-8
A 2014 QIC systematic review identified standard components of collaboratives. The
HEN organizations utilized these components, which included expert panels synthesizing
research, Plan-Do-Study-Act (PDSA) cycles, in-person learning sessions, multidisciplinary
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quality improvement teams, conference calls, and email support.8 The American Hospital
Association recommended four improvement tactics: 1) clear, regular communications
between HEN organization and hospitals 2) hospitals should report process measures 3) HEN
should intervene when process measures are out of alignment with goal 4) hospitals’
leadership engagement.9
Several patient safety researchers have openly criticized the design of the HEN
program and studies of its impact. The criticisms focus primarily on three areas.10 First, the
HENs did not standardize outcomes metrics which would have allowed for standardized
research across HENs. Second, all of the studies conducted on the effectiveness of HENs
were lacking a control group. Finally, the data, methods, and research were not available for
peer review.10
The Centers for Medicare & Medicaid’s (CMS) sponsored evaluation, conducted by
the Health Services Advisory Group, Inc. and Mathematica Policy Research in 2015,
addressed the latter two concerns. This study used 2011 through 2014 Medicare claims data,
the Medicare Patient Safety Monitoring System data, the National Healthcare Safety
Network data, the National Database of Nursing Quality Indicators, and the National Vital
Statistics System data.11 The researchers conducted an interrupted time series (ITS) analysis
to detect national trends in the HENs’ eleven targeted patient harm areas and difference-indifference (DID) regression analysis to estimate the HEN program’s impact on participants
compared to nonparticipants. Of the eleven HEN-targeted patient harm events, the ITS
analysis determined only one area, readmission rates, were significantly impacted.11 The
evaluation detected a 5.6% decline in 30-day all-cause readmissions from 2010 through
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2014.11 This decline fell short of the 20% goal established by CMS. In the DID regression,
HEN participants and nonparticipants performed the same for 30-day all-cause readmissions.
Ultimately, the formal evaluation concluded that the HEN program’s “impact on outcomes
and costs is inconclusive.”11
While the formal evaluation supported HEN critics, HEN supporters countered that
the lack of empirical evidence did not justify a conclusion of ineffectiveness.12,13 They
argued that setting up robust collaborative processes and metrics to drive improvements in
patient outcomes were significant accomplishments with the potential for future
improvement.12 One leader in population health stated that while quality improvement
collaboration is laudable, the industry needs additional peer review for decisions based on
data.14 Currently, CMS continues to support quality improvement collaborations similar to
the HENs.
The purpose of this study was to contribute to the HEN evidence base in several
ways. First, by comparing the HEN program’s outcomes with a nonparticipating control
group. Second, by using three distinct readmissions outcome variables (HF, AMI, and
pneumonia) instead of 30-day all-cause readmissions. Finally, by using readmission data
through 2017 to evaluate if improvements continued after the HEN program ended.
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Methods
Study Design
We compared changes in readmission rates between HEN participants and
nonparticipants using a fixed effects regression model with 36-month moving average data
for 2008 through 2017. Pre-post trends were analyzed while controlling for hospital
characteristics. The University of Texas School of Public Health’s Institutional Review
Board determined this study was exempt from human subjects’ protection.
Data Collection
The research database consisted of public-use data files linked to individual hospitals
by using the Medicare Provider Identification Number. We collected readmission data from
the CMS’s Hospital Compare archived data repository for a national sample of hospitals
identified as general acute care with at least 25 inpatient beds.15 Veterans Affairs (VA)
hospitals, rehabilitation hospitals, dedicated cancer centers, exclusive children’s hospitals,
mental health facilities, psychiatric hospitals, and long-term care facilities were excluded.
HEN participation was determined for the hospital sample from the “HEN Round 1 hospitals
2015” spreadsheet on the CMS Achieved Materials for the Partnership for Patients website.16
CMS annual impact files for fiscal year (FY) 2009 through 2018 were used to determine
core-based statistical areas (CBSA), US regional locations, and the disproportionate share
(DSH) ratio. When available, the correction notice data were used instead of the final rule
data. Ownership and state variables were obtained from the Hospital Compare’s FY18
archived flat file “Hospital General Information.” Teaching hospital designation was based
on CMS’s “2018 Reporting Cycle: Teaching Hospital List.”
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Variables and Measures
Each hospital’s HF, AMI, and pneumonia 30-day readmission rates were obtained for
each year. The rates represent the moving average of 36-months of data. For instance, the
FY2013 file contains data from July 2009 through June 2012. For the final year of the
regression analysis, 2012, the readmission data from the FY13 file were used. The final year
of the three-year moving average period was used for each study year. For example, 2010
through 2013 data were used for 2013. This method was used in other studies when the threeyear readmission rate was substituted for annual data.17
Time-invariant variables (US region, state, CBSAs, teaching designation, and
ownership) were used as controls in the descriptive analyses and the ordinary least squares
(OLS) regression model. The CMS impact file used the US Census Bureau’s classification
for regions: New England, Mid Atlantic, South Atlantic, East North Central, East South
Central, West North Central, West South Central, Mountain, and Pacific. The CBSA variable
was categorized as large urban, other urban, or rural. We categorized the ownership variable
into government-owned, private nonprofit, and for profit. We log-transformed the
disproportionate share ratio and the number of staffed beds variables to address skewness.
Analysis
The variables were time-invariant and time-varying. The 2012 data from the FY 2013
impact file was analyzed to develop graphs of the average 30-day readmission rates
throughout the ten periods categorized by HEN participation and nonparticipation. An
ordinary least squares (OLS) regression model of readmissions was estimated for 2008
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through 2011 using a binary variable to compare HEN participant-nonparticipant rates before
the program started.
The Hausman test was used to determine if a fixed effects or random effects
regression model was best for the data. The fixed effects regression model used panel data to
measure variation within a single hospital over time, using each hospital as its own control.18
The model included categorical independent variables for the number of staffed beds,
operating margin, DSH ratio, and case mix index. A binary variable for HEN participation
was zero for all hospitals through five periods (2008 through 2012) and one for HEN
participants starting in the sixth period, July 2012. This variable allowed us to test the effect
of HEN participation on the readmission rate while controlling for other time-invariant and
time-varying variables.
We removed hospitals that were missing outcome data and ran the fixed effects
regression model again to determine if strongly balanced panels achieved the same results.
We performed two sensitivity analyses. The first analysis determined the effect of changing
the original intervention period in the fixed effects model from period six to periods four,
five, and seven. The second analysis was to determine if there were differences in the HEN
program’s effect during and after the intervention. We eliminated periods that contained 18
months and 30 months of data after the HEN program completion in December 2014. The
statistical analyses were completed using Stata v14.2, College Station, Texas.19
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Results
Descriptive Statistics
The sample contained 3,275 HEN participating hospitals from all 26 HENs and 1,164
nonparticipating hospitals from throughout the United States who reported readmission
outcome data. The sample’s HEN participation rate of 73% was in line with the national
average of 72%. Hospitals with full panels of all three segments of outcome data were 1,083
HEN participants and 192 nonparticipants.
Table 1 displays the descriptive statistics for 2012, the year with most details on the
hospitals. HEN participation was disproportionately smaller in the West South Central
Region (Oklahoma, Arkansas, Texas, and Louisiana). The urban/rural geographic
distribution was similar for the two groups. HEN participants had twice the percentage of
teaching hospitals as nonparticipants. Finally, the nonparticipating cohort had twice the
percentage of for profit hospitals compared to the HEN participation cohort.
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Table 1: Descriptive Statistics for Time-invariant Variables
Descriptive Statistics for Time-invariant Variables
Variables
Region
New England
Mid Atlantic
South Atlantic
East North Central
East South Central
West North Central
West South Central
Mountain
Pacific
Geography
Rural
Small Urban
Large Urban
Teaching
Yes
No
Ownership
Government
Private Nonprofit
For Profit

HEN Participants
% of sample

Nonparticipants
% of sample

3.5%
13.6%
17.3%
16.1%
9.2%
8.7%
11.6%
6.5%
13.5%

7.21%
3.21%
20.35
14.42%
10.42%
4.49%
23.72%
7.37%
8.81%

24.4%
34.6%
41.0%

25.66%
33.33%
41.0%

28.4%
71.6%

13.75%
86.25%

22.1%
65.8%
12.1%

26.03%
45.62%
28.35%

Table 2 displays the time-varying variables for our fixed effects regression model. On
average, nonparticipants had a lower case mix index, fewer beds, and higher disproportionate
share ratio than the HEN participants. Figure 1 displays the 30-day readmission rate for AMI,
HF, and pneumonia by HEN participation.
Table 2: Descriptive Statistics for Time-varying Variables

Variables
Fixed Effect Variables
Case Mix Index
Beds
DSH Ratio

Descriptive Statics for Time-varying Variables
HEN Participants
Nonparticipants
Mean (sd)
Mean (sd)
1.51 (.290)
218.6 (188.5)
.287 (.164)

1.42 (.363)
156.4 (160.4)
.300 (.203)
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P-value (t-test)
<.001
<.001
<.001

Figure 1: 30-day Readmission Rates between HEN Participants and Nonparticipants

30-day Readmission Rate
27

25

Readmission %

23

21

19

17

15
05-08

06-09

07-10

08-11

09-12

10-13

11-14

12-15

AMI - NonHEN

HF - NonHEN

PN - NonHEN

AMI - HEN

HF - HEN

PN - HEN

13-16

14-17

OLS Regression Model
Table 3 displays the OLS regression results for HF, AMI, and pneumonia 30-day
readmission rates from the four periods ending in 2008 through 2011. The HEN coefficients
for HF (-.163, p<.001), AMI (-.106, p=.008), and pneumonia (-.253, p<.001) indicated that
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HEN hospitals were obtaining superior results before the HEN program began in 2012. The
coefficients for bed size, DSH, geographic location, were statistically significant (p<.001)
across all three readmission outcomes.
When the state was used as an independent variable compared to the region, it yielded
a higher adjusted R-squared, and many states were statistically significantly related to the
outcomes. However, state information was not relevant to our study. Therefore, we did not
list this information in Table 2.
Table 3: OLS Regression for Readmissions in 2008-2011
OLS Regression for Readmissions in 2008-2011
HF
AMI
Pneumonia
Coefficient P-value Coefficient P-value Coefficient
P-value

Variables
In Hen
No (reference)
Yes
-.163*
-.212*
Beds (log)
.729*
DSH Ratio (log)
Teaching
No (reference)
Yes
-.164
Hospital Type (omitted)
Geography
Rural (reference)
Small Urban
-.413*
Large Urban
.386*
State (not listed)
Year
2005-2008 (reference)
2006-2009
.200*
2007-2010
.294*
2008-2011
.193*
* Statistically significant at p < .05

<.001
<.001
<.001

-.106*
-.115*
.475*

.008
<.001
<.001

-.253*
.049*
.433*

<.001
<.001
<.001

<.001

.003

.938

.007

.852

<.001
<.001

-.080*
.357*

<.001
<.001

-.143*
.403*

.001
<.001

<.001
<.001
<.001

.032
-.093*
-.270*

.398
.014
<.001
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.141*
.198*
.275

.002
<.001
<.001

Fixed-effects Model
We analyzed hospital-level data using a multivariate fixed effects regression model of
the readmission outcomes (HF, AMI, and pneumonia). Both multivariate fixed effects and
random effects regressions were estimated using Stata. The Hausman test (p<.01) confirmed
that the fixed effects regression model was the best fit for the data.
Table 4 below shows the fixed effects result with all observations included in the
sample. There were a total of 76,900 hospital years in the data for HF (28,280), AMI
(20,936), and pneumonia (27,684). The HEN coefficients for AMI (-.073, p=.032) and PN
(.097, p=.003) were both statistically significant but in opposite directions. On average, HEN
participation decreased AMI readmission rates by .073 percentage points. However, HEN
participation was associated with a .097 percentage point increase in pneumonia readmission
rates. The HF readmission rate was not affected by HEN participation (.018, p=.639). The
disproportionate share ratio was statistically significant (p<.05) across all three outcome
measures.
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Table 4: Fixed Effects Model of Readmissions in 2008-2017
Fixed Effects Model of Readmissions in 2008-2017
HF
AMI
Pneumonia
Variables

Coefficient

P-value

Coefficient

P-value

Coefficient

.018
.030
.234*

.639
.526
.002

-.073*
-.062
.278*

.032
.165
<.001

.097*
-.105*
.134*

.003
.007
.035

.210*
.320*
.235*
-1.46*
-1.81*
-2.50*
-2.55*
-2.87*
-2.88*

<.001
<.001
<.001
<.001
<.001
<.001
<.001
<.001
<.001

.032
-.078*
-.239*
-1.60*
-2.01*
-2.85*
-2.95*
-3.54*
-3.86*

.224
.004
<.001
<.001
<.001
<.001
<.001
<.001
<.001

.147*
.224*
.318*
-.582*
-.933*
-1.33*
-1.13*
-1.30*
-1.54*

<.001
<.001
<.001
<.001
<.001
<.001
<.001
<.001
<.001

In Hen
No (reference)
Yes
Beds (log)
DSH Ratio (log)
Year
2005-2008 (reference)
2006-2009
2007-2010
2008-2011
2009-2012
2010-2013
2011-2014
2012-2015
2013-2016
2014-2017

P-value

* Statistically significant at p < .05

Table 5 displays the fixed effects results for hospitals with full panels (i.e., hospitals
with readmission rates reported for all ten study years). There were a total of 58,530 hospital
years in the data for HF (26,650), AMI (12,810), and pneumonia (19,070).
The HEN coefficients for the full sample mirrored those of the original sample. The
HEN participation coefficients for AMI (-.148, p=.001) and pneumonia (.103, p=.014) were
again significant in opposite directions. For HF, the HEN participation coefficient was not
significant (-.032, p=.439).
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Table 5: Fixed Effects Regression Results for Readmissions in 2008-2017 for Full Panels
Fixed Effects Regression Results for Readmissions in 2008-2017 for Full Panels
HF
AMI
Pneumonia
Variables
In Hen
No (reference)
Yes
Beds (log)
DSH Ratio (log)
Year
2005-2008 (reference)
2006-2009
2007-2010
2008-2011
2009-2012
2010-2013
2011-2014
2012-2015
2013-2016
2014-2017

Coefficient

P-value

Coefficient

P-value

Coefficient

-.032
.063
.185*

.439
.228
.016

-.148*
-.056
.232*

.001
.359
.010

.103*
-.102*
.048

.014
.048
.554

.206*
.315*
.245*
-1.45*
-1.76*
-2.45*
-2.51*
-2.81*
-2.82*

<.001
<.001
<.001
<.001
<.001
<.001
<.001
<.001
<.001

.027
.090*
-.243*
-1.63*
-1.98*
-2.83*
-2.91*
-3.51*
-3.81*

.465
.015
<.001
<.001
<.001
<.001
<.001
<.001
<.001

.144*
.215*
.312*
-.598*
-.949*
-1.37*
-1.09*
-1.27*
-1.51*

<.001
<.001
<.001
<.001
<.001
<.001
<.001
<.001
<.001

P-value

* Statistically significant at p < .05

Sensitivity Analysis
Table 6 displays the results of the first sensitivity analysis performed with the fixed
effects model with the HEN coefficient starting in periods four (July 2008 through June
2011), five (July 2009 through June 2012), and seven (July 2011 through June 2014).
Table 6: Sensitivity Analysis for the Start of the HEN Program
Sensitivity Analysis for the Start of the HEN Program
HF
AMI
HEN Coefficient
Period 4 (July 08-June 11)
Period 5 (July 09-June 12)
Period 6 (July 10-June 13)
Period 7 (July 11-June 14)

Coefficient
.008
.001
.018
.013

P-value
.854
.972
.693
.732

* Statistically significant at p < .05
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Coefficient
-.094*
-.072*
-.073*
-.074*

P-value
.011
.039
.032
.035

Pneumonia
Coefficient
.049
.064
.097*
.089*

P-value
.180
.056
.003
.007

The HF HEN coefficient was not significant for each of the four periods. Therefore,
no matter the timing of the HEN intervention in the statistical analysis, there was no effect of
HEN participation on the HF readmission rate.
The HEN coefficient for AMI was significant for each of the fixed effects
regressions, including period four, which was before the HEN program commenced.
Therefore, HEN participants started experiencing improved AMI readmission rates before
the program began.
Finally, HEN participants experienced worse pneumonia readmission rates during the
program. The HEN coefficient was not statistically significant until measured starting in the
sixth period.
A second sensitivity analysis was performed to eliminate the last two periods of this
study. Periods nine (July 2013 through July 2016) and ten (July 2014 through June 2017)
contained observations after the HEN program ended in December 2014. Table 7 displays the
results of dropping the last period and the last two periods from our analyses. When these
periods were dropped, there was not a significant change in the HEN participation
coefficients.
Table 7: Sensitivity Analysis for when the HEN Program Ended
Sensitivity Analysis for when the HEN Program Ended
HF
AMI
HEN Coefficient
All Ten Periods (original model)
Drop Period 10 (June 14-July 17)
Drop Periods 9 (June 13-June16) and 10

Coefficient
.018
.039
.032

P-value
.693
.334
.467

* Statistically significant at p < .05
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Coefficient
-.073*
-.061*
-.071*

P-value
.032
.085
.063

Pneumonia
Coefficient
.097*
.096*
.093*

P-value
.007
.005
.011

Conclusions

Our study added further empirical evidence to the ongoing debate on whether largescale quality improvement collaborations, such as the HEN program, have been effective.
Our study expanded on previous HEN research on readmissions by breaking out 30-day
readmissions into HF, AMI, and pneumonia. Also, our study sample contained years beyond
on the HEN program’s conclusion, allowing us to review sustainability after the HEN
program concluded.
In our sample, we were unable to show that HEN participation lead to declined
readmission rates. Only one HEN coefficient, AMI showed statistically significant
improvements for HEN participation (-.073, p=.032). However, a sensitivity analysis
determined that HEN participants started reducing readmission rates compared to the
nonparticipants before the HEN program commencing. The HEN participation coefficient for
HF was not significant (.018, p=.693). The pneumonia HEN coefficient determined that HEN
participation was associated with a statistically significant decline (.097, p=.007). The
statistically significant results from AMI and pneumonia were still less than one-tenth of a
percentage point resulting in a small effect size.
There are a few reasons as to why the HEN participants did not outperform
nonparticipants. Since HEN participating hospitals achieved better readmission rates before
the HEN program, it might have been difficult to accelerate improvements over the
nonparticipants further. Another possibility is that the nonparticipating hospitals gained
quality improvement knowledge through “spillover.”11 For instance, the nonparticipating
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hospitals may have experienced some benefits (e.g., receiving toolkits, attending
conferences, viewing webinars) without participating in time-intensive tasks such as regular
reporting of process measures and attending mandatory meetings.
Limitations
Our study had a few limitations. The first limitation was that we did not control for
mortality rates, which were possibly correlated with readmission rates.20
Next, we did not know which hospitals dropped out of the HEN program. Some
research shows that up to 30% of QIC participants drop out.21 Similarly, this study did not
have a variable to capture a hospital’s willingness to improve. The inability to quantify
motivation is a common limitation of quality improvement observational studies. Hospitals
with a high motivation to improve might have been more likely to join a HEN. Therefore, a
hospital's desire to improve leads to better outcomes not necessarily the HEN program.22
Omitted variable bias was also a concern with this study. Several quality
improvement efforts were ongoing at this time. These efforts included Meaningful Use,
accountable care organizations, and bundled payments.17 Our study does not control for when
hospitals joined these other programs or even the next round of HEN programs.
Additional Research
This study was the first known study that evaluated HEN participation with
nonparticipation on reducing hospital readmissions. Since this study was modeled after Ryan
et al’s readmission study,17 further research should combine their data with this study’s HEN
data. Combining the data sets would determine if HEN participation is significant while
controlling for value-based program participation.
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Also, additional research could determine the effect of programs such as the Hospital
to Home initiative or the American Heart Association’s Get with the Guidelines impact in
reducing cardiovascular readmission rates.23,24 Since HEN participants achieved better
outcomes for AMI readmissions before the HEN program, one possibility is that HEN
participants previously participated in one of these other programs.
Future QICs studies should evaluate using technology as a means to drive
effectiveness. The QIC systematic review on methods did not mention the use of
implementation software as a popular implementation tool. Using updated technologies may
lead to superior outcomes.
Additional research should focus on penalties and participation in QICs. In the past
decade, large QICs were preceded by policy developed penalties. For instance, Meaningful
Use threated penalties if providers did not adopt electronic health record (EHRs). However,
simultaneously, the federal government created Regional Extension Centers (RECs) to aid
EHR adoption. In 2012, the Hospital Readmissions Reduction Program began penalizing
hospitals for readmissions. While at the same time, the HENs assisted hospitals with
decreasing readmission rates. For example in one qualitative study, several interviewees cited
policy changes as a reason for joining a HEN.25 There were several studies published on
policy changes improving patient outcomes;26-28 however, to our knowledge no articles are
exploring how penalty enacting policies drive QIC participation.
The HEN program’s new iterations should be researched as well. Launched in 2015,
HEN 2.0 followed in the footsteps of the original HEN program. In version 2.0, CMS
distributed $110 million for one year to 17 quality improvement organizations to continue the
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HENs’ original work.29 In 2016, CMS announced a further continuation of the program with
the Hospital Improvement and Innovation Networks (HIIN). CMS awarded $347 million
through 2019 to 16 organizations to improve on the work started by the HEN program.30
However, there have been no known studies reviewing the effectiveness of these programs,
and we are unaware of any future evaluations.
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CONCLUSION
This study was the first known assessment of the HEN program since CMS’s
inconclusive formal evaluation in 2014. There were several significant findings in this study.
First, HEN participants had superior outcomes for CLABSIs and 30-day readmissions
compared to nonparticipants before the HEN program commenced. Next, there was no
evidence of the HEN participation’s effect on CLABSIs (p=.816). For 30-day readmission
rates, the pre-post fixed effect regression coefficients for HEN participants were varied for
HF (.018, p=.639), AMI (-.073, p=.032), and pneumonia (.097, p=.003).
Limitations
This study has several limitations for consideration. The first limitation is that critical
access hospitals (CAHs) were omitted because CMS did not report the CLABSI data in 2011.
Also, the readmission data were lacking for CAHs. Omitting these hospitals may have
created sampling bias. CAHs may have experienced a more significant benefit in
participating in the HEN program compared to larger hospitals.
Next, it is not known which hospitals dropped out of the HEN program. Some
research shows that up to 30% of QIC participants drop out of similar programs.92 Similarly,
this study did not have a variable to capture a hospital’s willingness to improve. The inability
to quantify motivation is a standard limitation of quality improvement observational studies.
Hospitals with a high motivation to improve might have been more likely to join a HEN.
Therefore, a hospital’s desire to improve that leads to better outcomes, not necessarily the
HEN program.65
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Omitted variable bias was also a concern with this study. Several quality
improvement efforts were ongoing at the same time as the HEN program. These efforts
included Meaningful Use, accountable care organizations, and bundled payments.84
Initiatives focusing on cardiovascular readmissions started a few years before the HEN
program.93,94 This study did not control for when hospitals joined these other programs.
For the first study, the CLABSI SIR data were available only from 2011 through
2014, which resulted in a short time-series panel. CLABSI SIR data before 2011 were not
available in the Hospital Compare data archive. In 2015, the National Healthcare Safety
Network updated how the CLABSI SIR was calculated.95 Therefore, we were unable to
directly compare 2015 CLABSI SIR data with the other years in our panel. In the second
study, the unique limitation was that we did not control for mortality rates, which were
possibly correlated with readmission rates.96
Future Research
This study is the first known study to evaluate the HEN program apart from CMS’s
formal evaluation. The study focused on two (CLABSIs and 30-day readmission rates) of the
12 outcomes targeted by the HEN program. These two outcomes were chosen because the
data were publicly available. Further research is needed on the other ten outcomes to
determine if the results are similar to this study.
Future QICs studies should evaluate using technology as a means to drive
effectiveness. The QIC systematic review with a focus on methods did not mention the use of
implementation software as an implementation tool. Using updated technologies may lead to
superior outcomes.
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Additional studies should also research monetary penalties for poor performance and
participation QICs. For the past decade in the US, large QICs were preceded by penalties
developed by policies. For instance, Meaningful Use issued penalties if providers did not
adopt electronic health record (EHRs). However, simultaneously, the federal government
created Regional Extension Centers (RECs) to aid EHR adoption. In 2012, the Hospital
Readmissions Reduction Program began penalizing hospitals for readmissions. While at the
same time, the HENs assisted hospitals with decreasing readmission rates. For example, in
one qualitative study, several interviewees cited policy changes for joining a HEN.71 There
were several studies on policy changes improving patient outcomes.97-99 However, no known
articles are exploring how penalty enacting policies drive QIC participation.
The HEN program’s new iterations should be researched and evaluated. Launched in
2015, HEN 2.0 followed in the footsteps of the original HEN program. In version 2.0, CMS
distributed $110 million for one year to 17 quality improvement organizations to continue the
HENs’ original work.23 In 2016, CMS announced a further continuation of the program with
the Hospital Improvement and Innovation Networks (HIIN). CMS awarded $347 million
through 2019 to 16 organizations to improve on the work started by the HEN program.24
However, there have been no known studies reviewing the effectiveness of these programs.
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